"
In Vivo Animal Model Evaluation of a Powerful Oral Nanomedicine for Treating Breast Cancer in BALB/c Mice Using 4T1 Cell Lines without Chemotherapy"
written by Zahra Fakhroueian, Alireza Massiha, Pegah Esmaeilzadeh, Mehdi Assmar, Afshin Zahedi, Pouriya Esmaeilzadeh, Sara Rezaei, Shahab Rabiei Lalehdasht,
published by
Advances in Nanoparticles,
Vol.11 No.3, 2022
has been cited by the following article(s):
|
[1]
|
Upregulation of EPSTI1/Drp1/AKT1 Signaling Pathways Using pDNA/Melittin Against Breast Cancer
Biochemical Genetics,
2024
DOI:10.1007/s10528-024-10806-5
|
|
|
|